雌激素阻斷劑市場：依產品類型、依應用、依配銷通路、按地區

2023年，雌激素阻斷劑的全球市場規模為150.2億美元，預計2023年至2030年年複合成長率為6.5%，到2030年達到233.4億美元。

圖 1. 2023 年按地區分類的雌激素阻斷劑全球市場佔有率(%)

雌激素阻斷劑是 FTM（女變男）患者使用的藥物，作為荷爾蒙替代療法 (HRT) 的一部分，以抑制體內雌激素的影響。它也具有促進男性第二性徵發育的作用。雌激素阻斷劑有不同類型，有些比其他更有效。

雌激素阻斷劑可以以錠劑或注射劑的形式服用。它們通常作為更大的 HRT 治療計劃的一部分開出，並且通常被使用者很好地耐受。在大多數情況下，您無需住院即可服用這些藥物，通常可以在家中服用。

市場動態

雌激素阻斷劑主要用於治療與荷爾蒙相關的疾病，例如卵巢症候群（PCOS）、子宮內膜異位症和乳癌。隨著這些疾病在國際上流行的增加，對雌激素阻斷劑的需求也在增加，從而推動了市場的擴張。

例如，2023年6月28日，世界衛生組織（WHO）發布的報告指出，卵巢症候群（PCOS）是影響育齡婦女的重要公共衛生問題，被認為是最常見的荷爾蒙激素之一。失調。據估計，這種疾病每年影響 8-13% 的育齡婦女，高達 70% 的病例未被確診。

另一方面，與任何藥物一樣，雌激素阻斷劑也有潛在的風險和副作用。典型的副作用包括潮熱、憂鬱、關節不適和膽固醇水平升高。在某些情況下，長期使用雌激素阻斷劑會增加心血管問題和骨質流失的風險。患者對雌激素阻斷劑的依從性和可接受性可能會受到安全性問題和可能的副作用的影響。

本研究的主要特點

• 本報告詳細分析了全球雌激素阻斷劑市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
• 它還闡明了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
• 它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球雌激素阻斷劑市場的主要企業。
• 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
• 雌激素阻斷劑的全球市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 透過用於分析全球雌激素阻斷劑市場的各種策略矩陣，將促進相關人員的決策。

目錄

第1章 研究目的與前提

• 研究目標
• 假設
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

• 市場動態
  • 促進因素
• 荷爾蒙相關疾病的盛行率增加
  • 抑制因素
• 副作用和安全問題
  • 機會
• 擴大適應症
• 影響分析
• 主要亮點
• 監管場景
• 產品發布/核准
• PEST分析
• 波特的分析
• 併購場景

第4章 全球雌激素阻斷劑市場－冠狀病毒(COVID-19) 大流行的影響

• 新型冠狀病毒感染疾病（COVID-19）的流行病學
• 供需面分析
• 經濟影響

第5章 全球雌激素阻斷劑市場，依產品類型，2018-2030

• 選擇性雌激素受體調節劑 (SERM)
• Aromatase酶抑制劑
• 雌激素受體下穩壓器(ERD)
• 其他

第6章 全球雌激素阻斷劑市場，依應用分類，2018-2030

• 乳癌治療
• 荷爾蒙替代療法（HRT）
• 不孕症治療
• 停經後骨質疏鬆症
• 其他

第7章 全球雌激素阻斷劑市場，依配銷通路，2018-2030

• 醫院藥房
• 零售藥房
• 線上藥房

第8章 全球雌激素阻斷劑市場，按地區，2018-2030

• 北美洲
• 美國
• 加拿大
• 歐洲
• 德國
• 英國
• 西班牙
• 法國
• 義大利
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 中國
• 印度
• 日本
• 澳洲
• 韓國
• ASEAN
• 其他亞太地區
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中東
• 海灣合作理事會國家
• 以色列
• 其他中東地區
• 非洲
• 南非
• 北非
• 中部非洲

第9章 競爭形勢

• Pfizer Inc.
• Novartis AG
• AstraZeneca PLC
• Eli Lilly and Company
• Merck & Co., Inc.
• Bristol Myers Squibb Company
• Sanofi SA
• AbbVie Inc.
• GlaxoSmithKline plc
• Olema Pharmaceuticals, Inc.
• Scorpion Therapeutics, Inc.
• Allorion Therapeutics Inc
• Carrick Therapeutics Limited
• Criterium, Inc.
• F.Hoffmann-La Roche

第10章 章

• 調查方法
• 關於出版商

The global estrogen blockers market size was valued at US$ 15.02 billion in 2023 and is expected to reach US$ 23.34 billion by 2030, growing at a CAGR of 6.5% from 2023 to 2030.

Figure 1. Global Estrogen Blockers Market Share (%), By Region, 2023

Estrogen blockers are medicines that are used by FTM (female to male) individuals as part of their hormone replacement therapy (HRT) to suppress the effects of estrogen in the body. They can also help to promote the development of male secondary sexual characteristics. There are many different types of estrogen blockers available, and some are more effective than others.

Estrogen blockers can be taken in the form of tablets or injections. They are usually prescribed as part of a larger HRT treatment plan and are generally well tolerated by individuals who take them. For the most part, a hospital stay is not required when taking these medications, and they can often be given at home.

Market Dynamics

Estrogen blockers are largely used to treat hormone-related diseases like polycystic ovary syndrome (PCOS), endometriosis, and breast cancer. The demand for estrogen blockers rises as the prevalence of these illnesses rises internationally, fueling market expansion.

For instance, on June 28, 2023, according to a report published by the World Health Organization, reported that polycystic ovary syndrome (PCOS) is a significant public health problem and considered as one of the commonest hormonal disturbances affecting women of reproductive age. The condition affects an estimated 8-13% of women of reproductive age every year, and up to 70% of cases are undiagnosed.

On the other hand, like any drug, estrogen blockers have potential risks and adverse effects. Hot flashes, mood swings, joint discomfort, and increases in cholesterol levels are examples of typical side effects. In some circumstances, long-term use of estrogen blockers may raise the risk of cardiovascular issues and bone loss. Patients' compliance with and acceptance of estrogen blockers may be impacted by safety worries and possible side effects.

Key features of the study:

• This report provides in-depth analysis of the global estrogen blockers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global estrogen blockers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer Inc., Novartis AG, AstraZeneca PLC, Eli Lilly and Company, Merck & Co., Inc., Bristol Myers Squibb Company, Sanofi S.A., AbbVie Inc., GlaxoSmithKline plc, Olema Pharmaceuticals, Inc., Scorpion Therapeutics, Inc., Allorion Therapeutics Inc, Carrick Therapeutics Limited, Criterium, Inc. and Hoffmann-La Roche
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global estrogen blockers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global estrogen blockers market

Detailed Segmentation:

• Global Estrogen Blockers Market, By Product Type:
  • Selective Estrogen Receptor Modulators (SERMs)
  • Aromatase Inhibitors
  • Estrogen Receptor Downregulators (ERDs)
  • Others
• Global Estrogen Blockers Market, By Application:
  • Breast Cancer Treatment
  • Hormone Replacement Therapy (HRT)
  • Infertility Treatment
  • Post-Menopausal Osteoporosis
  • Others
• Global Estrogen Blockers Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Estrogen Blockers Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Global Estrogen Blockers Market, By Company:
  • Pfizer Inc.
  • Novartis AG
  • AstraZeneca PLC
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Bristol Myers Squibb Company
  • Sanofi S.A.
  • AbbVie Inc.
  • GlaxoSmithKline plc
  • Olema Pharmaceuticals, Inc.
  • Scorpion Therapeutics, Inc.
  • Allorion Therapeutics Inc
  • Carrick Therapeutics Limited
  • Criterium, Inc.
  • F.Hoffmann-La Roche

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Estrogen Blockers, By Product Type
  • Market Estrogen Blockers, By Application
  • Market Estrogen Blockers, By Distribution Channel
  • Market Estrogen Blockers, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing Prevalence of Hormone-related Disorders
  • Restraints
• Side Effects and Safety Concerns
  • Opportunities
• Expansion of Indications
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Estrogen Blockers Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Estrogen Blockers Market , By Product Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Selective Estrogen Receptor Modulators (SERMs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Aromatase Inhibitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Estrogen Receptor Downregulators (ERDs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Estrogen Blockers Market , By Application, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Breast Cancer Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Hormone Replacement Therapy (HRT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Infertility Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Post-Menopausal Osteoporosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Estrogen Blockers Market , By Distribution Channel, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Estrogen Blockers Market , By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2019 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
• South Africa
• North Africa
• Central Africa

9. Competitive Landscape

• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
• AstraZeneca PLC
• Eli Lilly and Company
• Merck & Co., Inc.
• Bristol Myers Squibb Company
• Sanofi S.A.
• AbbVie Inc.
• GlaxoSmithKline plc
• Olema Pharmaceuticals, Inc.
• Scorpion Therapeutics, Inc.
• Allorion Therapeutics Inc
• Carrick Therapeutics Limited
• Criterium, Inc.
• F.Hoffmann-La Roche
• Analyst Views

10. Section

• Research Methodology
• About us